EUVIMEDEUVIMED entdecken
Crossref

Vacuum-assisted Biopsy and Surgical Correlation in HER2-positive and Triple-Negative Breast Cancer Subtypes in MRI Responders After Neoadjuvant Systemic Therapy. BISUCO TRIAL.

Sara Jimenez Arranz, Fernando Pizarro, Maria Angeles Fernandez Matamoros, Javier Torrens, Leisy Sotolongo, Maria Teresa Fernandez, Rocio Gonzalez, Manuel Delgado, Consuelo Sanz, Eva Ciruelos iD, Mario Martinez, Cristina Martin Arriscado und 4 weitere

Journal of Breast Imaging · 13.12.2025 · 7 (6) · 664-675

DOI: 10.1093/jbi/wbaf036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Imaging, online erschienen am 03.11.2025. Verfasst von Sara Jimenez Arranz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Magnetic Resonance Imaging, Image-Guided Biopsy, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Hospital Universitario 12 de Octubre, Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the diagnostic efficacy of 7G image-guided vacuum-assisted biopsy (VAB) in predicting pathological complete response (pCR) after neoadjuvant systemic therapy (NST) in HER2+ or triple-negative (TN) breast cancer (BC) showing complete response (CR) or almost-CR on MRI.

Methods

A prospective study was conducted from June 2018 to October 2022 on 25 HER2+ or TN operable BC patients who achieved CR or almost-CR on post-NST MRI. Presurgery, stereotactic or US-guided 7G VAB of the tumor bed was performed, and the pathological findings were compared with surgical results to evaluate the negative predictive value (NPV), accuracy, sensitivity, positive predictive value (PPV), and specificity in predicting residual disease.

Results

All tumors were invasive ductal carcinoma, with TN BC accounting for 52% (13/25) and HER2+ for 48% (12/25). MRI showed CR in 60% (15/25) of cases and almost-CR in 40% (10/25). Stereotactic VAB was performed in 84% (21/25) of cases and US-VAB in 16% (4/25), using 7G needles (average 10 samples) in all the cases. Posttreatment changes were demonstrated in all cases. Pathological CR was observed in 80% (20/25) of VAB cases and 84% (21/25) of surgical cases. Vacuum-assisted biopsy had a 100% NPV (95% CI, 83.2-100.0), 97.6% accuracy (95% CI, 92.9-100.0), 100% sensitivity (95% CI, 39.8-100.0), 80% PPV (95% CI, 28.4-99.5), and 95.2% specificity (95% CI, 76.2-99.9).

Conclusion

Image-guided VAB with 7G needles in HER2+ or TN BC with CR or almost-CR in post-NST MRI demonstrated a 100% NPV for detecting residual carcinoma when sample correlation and representativeness were ensured. Additional studies with larger patient cohorts are needed to confirm these promising results and to potentially omit surgery through image-guided VAB in selected TN BC and HER2+ BC cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMagnetic Resonance ImagingImage-Guided BiopsyBreast NeoplasmsHumansFemaleNeoadjuvant TherapyMiddle AgedProspective StudiesVacuumAdultErb-b2 Receptor Tyrosine KinasesAgedSensitivity and Specificity

Stichwörter der Autor:innen

breast MRIbreast biopsybreast cancerneoadjuvant systemic therapypathologic complete response (pCR)

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Hospital Universitario 12 de Octubre, Madrid, Spain.

ORCID-Profile: Eva Ciruelos

Förderung

  • Hospital Universitario 12 de Octubre, Madrid

Zitieren

APA

Jimenez Arranz, S., Pizarro, F., Fernandez Matamoros, M. A., Torrens, J., Sotolongo, L., Fernandez, M. T., Gonzalez, R., Delgado, M., Sanz, C., Ciruelos, E., Martinez, M., Martin Arriscado, C., Khan, A. M., Nawaz, N. E., Grobmyer, S., & Albillos, J. C. (2025). Vacuum-assisted Biopsy and Surgical Correlation in HER2-positive and Triple-Negative Breast Cancer Subtypes in MRI Responders After Neoadjuvant Systemic Therapy. BISUCO TRIAL. Journal of Breast Imaging, 7(6), 664-675. https://doi.org/10.1093/jbi/wbaf036

Vancouver

Jimenez Arranz S, Pizarro F, Fernandez Matamoros MA, Torrens J, Sotolongo L, Fernandez MT, et al. Vacuum-assisted Biopsy and Surgical Correlation in HER2-positive and Triple-Negative Breast Cancer Subtypes in MRI Responders After Neoadjuvant Systemic Therapy. BISUCO TRIAL. Journal of Breast Imaging. 2025;7(6):664-675. doi:10.1093/jbi/wbaf036

BibTeX
@article{JimenezArranz2025,
  author = {Jimenez Arranz, Sara and Pizarro, Fernando and Fernandez Matamoros, Maria Angeles and Torrens, Javier and Sotolongo, Leisy and Fernandez, Maria Teresa and Gonzalez, Rocio and Delgado, Manuel and Sanz, Consuelo and Ciruelos, Eva and Martinez, Mario and Martin Arriscado, Cristina and Khan, Asiya Maheen and Nawaz, Naghma Erum and Grobmyer, Stephen and Albillos, Jose Carmelo},
  title = {Vacuum-assisted Biopsy and Surgical Correlation in HER2-positive and Triple-Negative Breast Cancer Subtypes in MRI Responders After Neoadjuvant Systemic Therapy. BISUCO TRIAL},
  journal = {Journal of Breast Imaging},
  year = {2025},
  volume = {7},
  number = {6},
  pages = {664--675},
  doi = {10.1093/jbi/wbaf036}
}
Kostenlos starten →